Maha Othman and Marc Carrier
May 10, 2025, 06:35
Maha Othman: Pleasure to Interview the Brilliant Dr. Marc Carrier at Our Latest Thrombosis Canada Clot Conversation Podcast
Professor Maha Othman, Co-Chairman SSC on Disseminated intravascular coagulopathy at International Society on Thrombosis and Haemostasis, shared a post on X:
“Pleasure to interview the brilliant Dr. Marc Carrier at our latest Thrombosis Canada clot conversation podcast. Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose; preventing recurrent VTE in cancer patients while resulting in less bleeding.”
Quoting Thrombosis Canada‘s post:
“New study, new standard? Reduced-dose apixaban may change the game in cancer-associated thrombosis. Dr. Carrier explains why.
Listen here.”
Find more on Hemostasis Today.
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch
-
Feb 23, 2026, 16:36Stéphanie Roullet։ New Method to Explore Primary Haemostasis in Cirrhotic Patients
-
Feb 23, 2026, 16:33Salvatore Massimo Petrina: Top 5 Game-Changers in the AHA and ACC PE Guidelines
-
Feb 23, 2026, 16:21Azin Alizadehasl: Introducing the Second Edition of a New Book on Echocardiography and Cardiac MRI
-
Feb 23, 2026, 16:16Kalyan Roy: When and Why Blood Irradiation Matters in Transfusion Medicine
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine